低强度激光治疗静脉性溃疡:基于护理结局分类的随机对照试验方案
本研究为一项前瞻性随机对照试验方案,计划纳入40例成人活动性静脉性溃疡患者,比较辅助低强度激光治疗与常规组织修复的效果。两组均接受局部药物和压力治疗,干预组加用低强度激光,每周随访至溃疡愈合或最长16周,采用护理结局分类(NOC)的14项临床指标评估组织修复,主要终点为伤口缩小和瘢痕形成。
要点
- 辅助低强度激光治疗静脉性溃疡的疗效证据仍有限。
- 试验计划纳入40例患者,随机分为常规治疗组和加用激光组。
- 主要终点为伤口缩小和瘢痕形成,采用NOC的14项指标评估。
核心结论
- 本试验方案旨在验证辅助低强度激光治疗能否提升静脉性溃疡治疗的质量、速度和效果。
研究设计与样本
- 前瞻性随机对照试验,计划招募40例男女成人活动性静脉性溃疡患者,采用密封信封法随机分组。
关键数值与推荐
- 两组均接受局部药物和压力治疗,干预组额外接受辅助低强度激光治疗。
- 每周随访至溃疡愈合或最长16周。
- 采用NOC中伤口愈合(二期愈合)和组织完整性(皮肤和黏膜)的14项临床指标评估组织修复。
- 主要终点为伤口缩小和瘢痕形成。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Different methods are available for the treatment of venous ulcers. Most current approaches focus on a combination of topical and compressive therapy. Adjuvant low-level laser therapy may be helpful in lesions with a protracted healing course, but evidence for its use is still limited. This paper describes the protocol of a randomized controlled trial designed to compare the effect of adjuvant low-level laser therapy versus conventional venous ulcer tissue repair, evaluated by a nurse using clinical indicators from the Nursing Outcomes Classification (NOC). METHODS/DESIGN: For this prospective randomized controlled trial, 40 adult patients of both sexes with active venous ulcers will be recruited. Subjects will be selected by the sealed-envelope method without any annotation or external identification that might refer to the type of study group. At the time of unblinding, a label with the description of the group to which the patient belongs (that is, control or intervention) will be found inside the envelope. Conventional treatment (topical medication and compressive therapy) will be offered to both groups. Additionally, the intervention group will receive adjuvant low-level laser therapy. All patients will be followed weekly until ulcer healing or for a maximum of 16 weeks. Evaluation of tissue repair will be based on 14 clinical indicators drawn from NOC for wound healing (secondary intention) and tissue integrity (skin and mucous membranes). The primary endpoint will be decreased wound size and scar formation. This laser therapy is expected to enhance the quality, speed, and effectiveness of the treatment of venous ulcers, a chronic condition. This should reduce associated costs to the health service and allow patients to resume their daily activities sooner. DISCUSSION: This randomized clinical trial will use a validated method to investigate the effect of a novel intervention for the treatment of venous ulcers. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03229330 . Registered on July 2017.
引用
- Bavaresco T, Pires AUB, Moraes VM, et al. Low-level laser therapy for treatment of venous ulcers evaluated with the Nursing Outcome Classification: study protocol for a randomized controlled trial. Trials. 2018. PMID: 30001202. doi:10.1186/s13063-018-2729-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。